C3G

Clinical trials for C3G explained in plain language.

Never miss a new study

Get alerted when new C3G trials appear

Sign up with your email to follow new studies for C3G, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 2 Terminated 1

Experimental drug targets protein leak in kidney patients

Disease control Terminated

This study tested a drug called OMS721 (narsoplimab) in 31 people with four types of kidney disease: IgA nephropathy, lupus nephritis, membranous nephropathy, and C3 glomerulopathy. The main goal was to see if the drug is safe and if it reduces protein in the urine, a sign of kid…

Matched conditions: C3G

Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated May 11, 2026 20:49 UTC

C3G

Get alerted when new C3G trials appear

Experimental drug targets protein leak in kidney patients